278 related articles for article (PubMed ID: 16855922)
1. Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.
Socan M; Prosenc K; Vegnuti M
Wien Klin Wochenschr; 2006 Jun; 118(11-12):336-40. PubMed ID: 16855922
[TBL] [Abstract][Full Text] [Related]
2. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.
Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D
BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894
[TBL] [Abstract][Full Text] [Related]
4. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia.
Jõgi P; Oona M; Toompere K; Leedo S; Epstein J; Lutsar I
Vaccine; 2014 Sep; 32(41):5311-5. PubMed ID: 25093282
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.
Wanlapakorn N; Ngaovithunvong V; Thongmee T; Vichaiwattana P; Vongpunsawad S; Poovorawan Y
PLoS One; 2016; 11(2):e0148338. PubMed ID: 26837004
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
[TBL] [Abstract][Full Text] [Related]
8. Seroepidemiology of pertussis in Huzhou: A population-based, cross-sectional study.
Liu Y; Zhang C; Wang Y; Luo X; Liu G; Zhang Z; Shen J
PLoS One; 2024; 19(5):e0303508. PubMed ID: 38768133
[TBL] [Abstract][Full Text] [Related]
9. Pertussis seroprevalence in korean adolescents and adults using anti-pertussis toxin immunoglobulin G.
Lee SY; Han SB; Bae EY; Kim JH; Kang JH; Park YJ; Ma SH
J Korean Med Sci; 2014 May; 29(5):652-6. PubMed ID: 24851020
[TBL] [Abstract][Full Text] [Related]
10. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.
Diez-Domingo J; Ballester A; Baldó JM; Planelles MV; Villarroya JV; Alvarez T; Carmen Peidró M; Calero P; Garcés MD; Sorribes I; Graullera M; Jubert A; San-Martín M; González A
J Infect; 2004 Oct; 49(3):242-7. PubMed ID: 15337342
[TBL] [Abstract][Full Text] [Related]
11. [Seroprevalence of pertussis toxin antibody in Manisa province of Turkey, after six years implementation of acellular pertussis vaccine].
Özbek ÖA; Öktem İMA; Hekimoğlu CH; Sekreter Ö; Emek M; Atasoylu G; Açıkgöz A; Demirpençe N; Ceylan A; Baykal ES; Ünal B
Mikrobiyol Bul; 2018 Apr; 52(2):180-189. PubMed ID: 29933735
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program.
Hallander HO; Andersson M; Gustafsson L; Ljungman M; Netterlid E
APMIS; 2009 Dec; 117(12):912-22. PubMed ID: 20078557
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Bordetella pertussis immunoglobulin G antibodies among children in Samsun, Turkey.
Ozkal A; Sensoy G; Acuner C; Belet N; Güney AK
Turk J Pediatr; 2012; 54(1):15-9. PubMed ID: 22397036
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children.
Syed MA; Ahmed W; Naeem A; Bokhari H
J Coll Physicians Surg Pak; 2012 Oct; 22(10):677-8. PubMed ID: 23058160
[TBL] [Abstract][Full Text] [Related]
15. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I
Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
[TBL] [Abstract][Full Text] [Related]
16. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
Sato Y; Sato H
Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
[TBL] [Abstract][Full Text] [Related]
17. Age-related differences in antibody avidities to pertussis toxin and filamentous hemagglutinin in a healthy Japanese population.
Fumimoto R; Otsuka N; Sunagawa T; Tanaka-Taya K; Kamiya H; Kamachi K
Vaccine; 2019 Apr; 37(18):2463-2469. PubMed ID: 30930008
[TBL] [Abstract][Full Text] [Related]
18. Comparison of anti-pertussis toxin ELISA and agglutination assays to assess immune responses to pertussis.
Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
Infect Dis (Lond); 2017 Aug; 49(8):594-600. PubMed ID: 28335677
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants.
Gonik B; Puder KS; Gonik N; Kruger M
Infect Dis Obstet Gynecol; 2005 Jun; 13(2):59-61. PubMed ID: 16011994
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]